ArticleAdvances in experimental medicine and biology2023
Graph-Based Disease Prediction in Neuroimaging: Investigating the Impact of Feature Selection.
Article in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biomedical machine learning, data often appear in the form of graphs. Biological systems such as protein interactions and ecological or brain networks are instances of applications that benefit from graph representations. Geometric deep learning is an arising field of techniques that has extended deep neural networks to non-Euclidean domains such as graphs. In particular, graph convolutional neural networks have achieved advanced performance in semi-supervised learning in those domains. Over the last years, these methods have gained traction in neuroscience as they could be the key to a deeper understanding in clinical diagnosis at the systems or network level (for an individual brain but also for across a cohort of subjects). As a proof-of-principle, we study and validate a previous implementation of graph-based semi-supervised classification using a ridge classifier and graph convolutional neural networks. The models are trained on population graphs that integrate imaging and phenotypic information. Our analysis employs neuroimaging data of structural and functional connectivity for prediction of neurodevelopmental and neurodegenerative disorders. Here, we particularly study the effect of different strategies to reduce the dimensionality of the neuroimaging features on the graph nodes on the classification performance.
Indexed as
Identifiers
37486497What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.